Showing posts with label Diabetic retinopathy. Show all posts
Showing posts with label Diabetic retinopathy. Show all posts

Monday, December 06, 2010


People with type 2 diabetes who drink alcohol are at increased risk for blurry vision unrelated to retinopathy, according to Joline W.J. Beulens, PhD, of University Medical Centre Utrecht in the Netherlands, and colleagues published in the journal Diabetic Medicine.

There was two-line loss of acuity in participants reporting one to 14 drinks or more a week compared with those who don't drink. They calculated that each additional drink per week increased the risk of two-line acuity loss by 2%.

While moderate drinking did not increase the risk for or progression of retinopathy in a study of more than 1,200 diabetics it nearly doubled the risk of losing two eye-chart lines of visual acuity over an average of five years.

Retinal vascular lesions by mydriatic stereoscopic photography, were no more common in diabetics who drank than in those who didn't. The study authors theorized, Alcohol is known for its neurotoxic properties, which could induce oxidative damage to the retina and the optic nerve, leading to visual loss."
Enhanced by Zemanta

Tuesday, November 30, 2010

Glucose Control May Influence Outcome Of Ranibizumab Treatment For Diabetic Macular Edema.

Diabetic macular edema.Image via Wikipedia

According to a study published in the Journal of Diabetes and its Complications, glucose control influences the outcome of ranibizumab treatment for diabetic macular edema.

This retrospective study enrolled 65 eyes of 65 patients with persistent DME treated with intravitreal ranibizumab injection. The main outcome measures were the change in best corrected visual acuity (BCVA), the central subfield macular thickness (CSMT) recorded with optical coherence tomography (OCT), and its correlation with the serum hemoglobin A1c values (HbA1c).

Researchers found that serum levels of glycated hemoglobin (HbA1c) showed a negative correlation with the change in central subfield macular thickness (CSMT) after intravitreal injection of ranibizumab.
Enhanced by Zemanta

Tuesday, September 21, 2010

Fundus photo showing focal laser surgery for d...Image via WikipediaMedWire reported that, according to a study published in the journal Diabetes, high serum levels of prolactin are associated with a decreased risk for diabetic retinopathy.
After working with rats and also measuring serum prolactin in 40 nondiabetic and 181 diabetic men with various degrees of retinopathy, researchers led by Carmen Clapp of the Cellular and Molecular Biology institute at the Institute of Neurobiology found that mean prolactin levels were higher in diabetic versus nondiabetic individuals (34.1 vs. 16.3 ng/ml), but lower in diabetic patients with proliferative retinopathy than in those without this complication (26.7 vs. 32.8 ng/ml). Notably, the results were the same, regardless of whether patients had type 1 or type 2 diabetes.
The researchers conclude that prolactin is an important systemic inhibitor of diabetes induced retinal hypervasopermeability after its intra ocular conversion into vasoinhibins.

Enhanced by Zemanta

Thursday, August 12, 2010

Proliferative retinopathy Description: Prolife...Image via WikipediaThe Los Angeles Times reports, Nearly three in 10 Americans with diabetes over the age of 40 suffer from vision impairment caused by diabetic retinopathy, and about 4.4% have a form of the condition so severe it threatens their eyesight, according to a study published in the August 11 issue of the Journal of the American Medical Association.

HealthDay reported that the news wasn't all bad, however. The findings suggest that good control of blood sugar, blood pressure, and cholesterol can go a long way toward preventing or slowing diabetic eye disease. For the study, CDC researchers reviewed data from the National Health and Nutrition Examination Survey from 2005 to 2008, which included nearly 7,000 people over age 40, 1,006 of whom had diabetes.

Focusing on specific gender and ethnic/racial demographics, reported that 31.6% men and 25.7% of women over age 40 who have diabetes are estimated to have diabetic retinopathy, while 38.8% of non-Hispanic blacks were estimated to have diabetic retinopathy, 34% of Mexican-Americans, and 26.4% of non-Hispanic whites. Interestingly, age was not a major factor among the study group.

Independent risk factors for diabetic retinopathy included male sex, higher hemoglobin A1c level, longer duration of diabetes, and higher systolic blood pressure, with respective odds ratios of 2.07, 1.45, 1.06 per year of duration, and 1.03 per millimeter of mercury.
Enhanced by Zemanta

Sunday, August 01, 2010

Tribal Clinic Working On Telemedecine

Low-resolution image of the Oregoh Health and ...Image via Wikipedia

Yellowhawk Tribal Health Center near Pendleton, OR, is one of two tribal clinics (the other is in Wichita, Kan.) working on a test of long-distance eye care with researchers from Oregon Health & Science University and Legacy Health's Devers Eye Institute. This effort waqs highlighted by The Oregonian

At Yellowhawk, patients with diabetes can undergo a retinal scan with a $20,000-plus non-mydriatic camera, which can photograph the retina without dilating the pupil. Next, the images are uploaded to the Internet and sent to doctors in Portland who check for signs of retinopathy. The images also allow doctors to check for glaucoma or macular degeneration.
Enhanced by Zemanta

Tuesday, July 13, 2010

Alcohol consumption in diabetics linked to decline in visual acuity

Fundus photo showing focal laser surgery for d...Image via Wikipedia

New research shows that patients with diabetes mellitus who drink moderate amounts of alcohol are not at an increased risk for developing retinopathy, but are at an increased risk for losing visual acuity.

"The relationship with the decline in visual acuity was continuous through the distribution of alcohol consumption," report Joline Beulens of University Medical Centre, Utrecht, The Netherlands.

In this study, the group analyzed data on 1239 individuals aged 55 to 81 years with Type 2 diabetes previously enrolled in the AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial.
Alcohol consumption was self-reported, with moderate drinking defined as one to 14 drinks per week and heavy drinking defined as more than 14 drinks weekly.

After a mean follow-up of 5.5 years, 182 individuals were diagnosed with diabetic retinopathy, while 640 had retinal vascular lesions, and 693 had declines in visual acuity.

No type of alcoholic beverage was worse than any other, although the magnitude of association was slightly increased with beer compared with wine,
Enhanced by Zemanta

Sunday, July 04, 2010

Two Therapies That May Slow Progress Of Diabetic Retinopathy

Description: Fundus photo showing scatter lase...Image via Wikipedia

The Los Angeles Times "Booster Shots" blog reported that, according to data published June 29 in the New England Journal of Medicine and presented at the American Diabetes Association meeting, doctors said they have identified two therapies that may slow the progress of diabetic retinopathy.

After examining data on a subset of 2,856 people from the ACCORD study, researchers found that "people with type 2 diabetes who adhere to intensive blood sugar control, compared with standard blood sugar control, have reduced progression of retinopathy. In addition, patients treated with a combination of a cholesterol-lowering statin and fibrate drugs also had a lower rate of progression compared with patients taking statins alone.
Enhanced by Zemanta

Monday, May 17, 2010


A new technique, developed by scientists at ARC Vision Centre and Australian National University (ANU), can quantify damage caused by serious eye diseases.

Called multifocal pupillography, the method involves monitoring minute responses of the eye's pupil to light signals in different parts of the patient's visual field.

ARC Vision Centre and Australian National University (ANU) researchers led by Ted Maddess and Andrew James are pioneering this area of study for painless detection and monitoring of glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy.

The technique relies on a feedback loop of nerve signals, which flow from each eye to the brain and back again to both pupils of the eyes by a secondary pathway, Maddess explains.

In our research we have been trying to localise the responses of the pupil to particular places across the visual field and hence, the eye's retina, said Maddes.

Reblog this post [with Zemanta]

Saturday, August 01, 2009

Ozurdex Implant Approved for Macular Edema

OCT scan of a retina at 800nm with an axial re...Image via Wikipedia

An injectable eye implant approved by the U.S. Food and Drug Administration Thursday is the first product sanctioned to treat the eye disorder macular edema when it is caused by blockage of the retinal vein.

The Ozurdex eye implant treats macular edema by delivering a high concentration of the corticosteroid dexamethasone.

Macular edema occurs when the eye's macula -- a part of the retina -- swells because of fluid accumulation from leaking or blocked retinal veins. In a news release, device maker Allergan, Inc. said retinal vein occlusion is a significant cause of vision loss and the second most common disease of the retinal veins, behind diabetic retinopathy.

The implant, which is biodegradable, was evaluated in a pair of clinical studies involving about 1,300 people.

The treatment, to be injected in a physician's office, is expected to be available later this year

Reblog this post [with Zemanta]

Wednesday, February 18, 2009

Imaging-analysis technique allows diagnosis of diabetes-related eye problems over the Internet.

Wired News reports that an imaging-analysis technique developed by researchers at the University of Tennessee for finding defects in semiconductors is now being used to diagnose the eye problems associated with diabetes over the Internet. Pictures of the retinas of patients with diabetes are uploaded to a server that compares them to a database of thousands of other images of healthy and diseased eyes.

Algorithms can assign a disease level to the new eye image by looking at the same factors, mainly damage to blood vessels, that an eye doctor would. Currently, more than 25 million Americans suffer from diabetes, which, if left untreated, can cause blindness, among other physical problems. This new technology could help reduce the cost and increase the availability of screening for the eye problems that impair the vision of thousands of patients each year.

Thursday, January 29, 2009

Cataracts are the most common age-related eye disease, with more than 17 percent of Americans age 40 and over affected. The main cause, aside from plain old aging, is exposure to ultraviolet B radiation in sunlight. People can reduce their risk and delay the need for surgery to remove a clouded lens by wearing sunglasses and brimmed hats while outside.

At present, cataract surgery has been refined so that the super small incisions are self-sealing. Besides cataracts, eye conditions such as glaucoma and macular degeneration also affect seniors, although they are more insidious. Typically, medications are used to slow the damage caused by glaucoma. Meanwhile, high doses of supplements, including vitamins C and E and beta carotene and the mineral zinc, have been found to slow the progression of AMD in several trials.

This report was published in the US News and World Report

It was also noted that people with diabetes have added reason to worry: Diabetic retinopathy affects some 40 percent of people with the disease, with 8 percent of all diabetics facing significant vision loss. Keeping your blood sugar levels under control reduces the risk of harm.

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review